LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 19.76%188.57M | 37.92%49.17M | -4.58%52.13M | 11.46%50.52M | 68.19%36.75M | -14.06%157.46M | 20.04%35.65M | 10.54%54.63M | -34.02%45.32M | -38.29%21.85M |
Net income from continuing operations | 18.40%140.64M | 18.26%36.01M | 54.83%38.1M | 8.79%32.72M | 0.49%33.82M | -21.85%118.78M | -15.71%30.45M | -36.86%24.61M | -20.39%30.07M | -13.98%33.66M |
Operating gains losses | -132.66%-2.99M | 49.91%-288K | -443.95%-540K | -98.69%60K | -144.62%-2.22M | 807.73%9.16M | -377.78%-575K | 37.72%157K | 707.56%4.6M | 4,086.55%4.98M |
Depreciation and amortization | 23.45%27.5M | 1.11%6.91M | 13.50%6.84M | 47.39%6.86M | 44.69%6.89M | 16.85%22.27M | 43.35%6.83M | 26.27%6.02M | -2.64%4.66M | 0.38%4.76M |
Deferred tax | 46.51%8.73M | ---- | ---- | ---- | ---- | 130.02%5.96M | ---- | ---- | ---- | ---- |
Other non cashItems | -65.52%-13.86M | -1,215.21%-8.13M | 37.13%-2.29M | 35.47%-1.61M | -13.24%-1.83M | -45.04%-8.37M | 67.15%-618K | -164.80%-3.64M | -79.97%-2.5M | -43.14%-1.62M |
Change in working capital | 102.68%748K | 113.64%2.44M | -58.30%5.57M | -68.46%1.06M | 68.93%-8.32M | -333.88%-27.91M | -1,321.14%-17.85M | 1,253.90%13.36M | -83.93%3.36M | -135.01%-26.77M |
-Change in other working capital | 102.68%748K | 113.64%2.44M | -58.30%5.57M | -68.46%1.06M | 68.93%-8.32M | -333.88%-27.91M | -1,321.14%-17.85M | 1,253.90%13.36M | -83.93%3.36M | -135.01%-26.77M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 19.76%188.57M | 37.92%49.17M | -4.58%52.13M | 11.46%50.52M | 68.19%36.75M | -14.06%157.46M | 20.04%35.65M | 10.54%54.63M | -34.02%45.32M | -38.29%21.85M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -802.55%-399.16M | -406.39%-147.59M | -187.15%-58.01M | -116.35%-180.43M | 82.63%-13.13M | 95.23%-44.23M | 121.20%48.17M | 147.17%66.56M | 52.24%-83.4M | 80.28%-75.56M |
Net investment purchase and sale | -124.32%-61.75M | -327.50%-79.5M | -98.31%2.56M | -132.57%-8.03M | -46.09%23.22M | 206.11%253.95M | -20.63%34.94M | 1,539.39%151.29M | 156.31%24.65M | 118.80%43.06M |
Net proceeds payment for loan | 0.13%-337.66M | -721.39%-68.71M | 57.61%-56.6M | -74.60%-170.04M | 64.22%-42.31M | 48.77%-338.11M | 104.44%11.06M | -4.01%-133.53M | 24.18%-97.39M | 23.20%-118.24M |
Net PPE purchase and sale | -26.89%-11.74M | -24.31%-3.63M | -24.59%-4.31M | 7.08%-1.38M | -74.21%-2.43M | -32.03%-9.25M | -29.25%-2.92M | -39.28%-3.46M | -55.39%-1.48M | -6.10%-1.39M |
Net business purchase and sale | -103.10%-1.38M | ---400K | -100.51%-240K | --0 | -475.97%-743K | 1,803.52%44.56M | --0 | 6,772.90%46.78M | -32.49%-2.08M | 50.38%-129K |
Net other investing changes | 189.34%13.38M | -8.84%4.64M | -89.38%582K | 86.21%-978K | 698.34%9.13M | 126.70%4.62M | 125.69%5.09M | 470.24%5.48M | -4,532.50%-7.09M | -17.34%1.14M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -802.55%-399.16M | -406.39%-147.59M | -187.15%-58.01M | -116.35%-180.43M | 82.63%-13.13M | 95.23%-44.23M | 121.20%48.17M | 147.17%66.56M | 52.24%-83.4M | 80.28%-75.56M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 374.65%289.46M | 81.86%-99.98M | -19.67%280.82M | 80.39%18.34M | 4.79%90.29M | 67.94%-105.39M | -846.30%-551.29M | 415.32%349.57M | 102.19%10.17M | -50.17%86.16M |
Increase decrease in deposit | 252.11%577.77M | 90.40%-41.52M | -43.68%316.82M | 150.35%76.17M | 22.14%226.3M | 122.22%164.09M | -2.28%-432.46M | 611.62%562.56M | 65.05%-151.29M | -18.44%185.27M |
Net issuance payments of debt | -8.22%-223.86M | 59.39%-42.06M | 89.89%-19.78M | -123.97%-42.47M | -40.97%-119.55M | -143.45%-206.86M | -120.31%-103.57M | -1,732.54%-195.64M | 1,452.27%177.16M | -158.59%-84.81M |
Net commonstock issuance | 94.92%-251K | --0 | --0 | 93.23%-188K | ---63K | 66.40%-4.94M | --0 | ---2.17M | 57.66%-2.78M | --0 |
Cash dividends paid | -11.41%-62.26M | -6.42%-16.04M | -6.45%-16.04M | -17.23%-15.09M | -17.25%-15.09M | -12.30%-55.89M | -17.23%-15.07M | -17.42%-15.07M | -7.35%-12.87M | -6.52%-12.87M |
Proceeds from stock option exercised by employees | -32.97%61K | --0 | ---- | ---- | ---- | --91K | --91K | ---- | ---- | ---- |
Net other financing activities | -6.18%-1.99M | -31.21%-370K | -125.23%-241K | -44.64%-81K | 9.15%-1.3M | -7.20%-1.88M | 30.37%-282K | -87.72%-107K | 29.11%-56K | -18.35%-1.43M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 374.65%289.46M | 81.86%-99.98M | -19.67%280.82M | 80.39%18.34M | 4.79%90.29M | 67.94%-105.39M | -846.30%-551.29M | 415.32%349.57M | 102.19%10.17M | -50.17%86.16M |
Net cash flow | ||||||||||
Beginning cash position | 3.97%205.19M | -28.28%482.46M | 2.79%207.52M | 38.86%319.09M | 3.97%205.19M | -84.45%197.35M | 109.51%672.65M | -61.44%201.89M | -79.00%229.8M | -84.45%197.35M |
Current changes in cash | 906.08%78.87M | 57.56%-198.4M | -41.60%274.94M | -299.80%-111.57M | 251.06%113.9M | 100.73%7.84M | -277.88%-467.47M | 332.41%470.77M | 95.11%-27.91M | 118.55%32.45M |
End cash position | 38.44%284.06M | 38.44%284.06M | -28.28%482.46M | 2.79%207.52M | 38.86%319.09M | 3.97%205.19M | 3.97%205.19M | 109.51%672.65M | -61.44%201.89M | -79.00%229.8M |
Free cash flow | 19.31%176.83M | 39.13%45.54M | -6.55%47.83M | 12.09%49.14M | 67.78%34.32M | -15.90%148.2M | 19.28%32.73M | 9.02%51.18M | -35.28%43.84M | -40.00%20.46M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |